Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
November 9, 2013
MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells
L Y Zhao, J Zhang, B Guo, et al.
Journal of Neuro-Oncology
|
January 1, 1995
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report
D D Bigner, M Brown, R E Coleman, et al.
Oncology Reports
|
September 2, 2015
Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors
Q F Sun, X N Zhao, C L Peng, et al.
Nature Materials
|
December 18, 2019
Multi-messenger nanoprobes of hidden magnetism in a strained manganite
A S McLeod, Jingdi Zhang, M Q Gu, et al.
Journal of Animal Science
|
August 22, 2007
Effects of dietary methionine and lysine sources on nutrient digestion, nitrogen utilization, and duodenal amino acid flow in growing goats
Z H Sun, Z L Tan, S M Liu, et al.
Oncogenesis
|
August 1, 2017
MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1
L Y Zhao, D D Tong, M Xue, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
G Akabani, I Cokgor, R E Coleman, et al.
Molecular and Cellular Biochemistry
|
July 1, 1997
Construction of a human heart cDNA library and identification of cardiovascular based genes (CVBest)
C C Liew, D M Hwang, R X Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2000
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
I Cokgor, G Akabani, C T Kuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results
D D Bigner, M T Brown, A H Friedman, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
November 9, 2013
MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells
L Y Zhao, J Zhang, B Guo, et al.
Journal of Neuro-Oncology
|
January 1, 1995
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report
D D Bigner, M Brown, R E Coleman, et al.
Oncology Reports
|
September 2, 2015
Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors
Q F Sun, X N Zhao, C L Peng, et al.
Nature Materials
|
December 18, 2019
Multi-messenger nanoprobes of hidden magnetism in a strained manganite
A S McLeod, Jingdi Zhang, M Q Gu, et al.
Journal of Animal Science
|
August 22, 2007
Effects of dietary methionine and lysine sources on nutrient digestion, nitrogen utilization, and duodenal amino acid flow in growing goats
Z H Sun, Z L Tan, S M Liu, et al.
Oncogenesis
|
August 1, 2017
MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1
L Y Zhao, D D Tong, M Xue, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
G Akabani, I Cokgor, R E Coleman, et al.
Molecular and Cellular Biochemistry
|
July 1, 1997
Construction of a human heart cDNA library and identification of cardiovascular based genes (CVBest)
C C Liew, D M Hwang, R X Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2000
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
I Cokgor, G Akabani, C T Kuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results
D D Bigner, M T Brown, A H Friedman, et al.
Page
of 5